[Protective and curative effects of diethyldithiocarbamate on galactosamine hepatitis in the rat (author's transl)].
Diethyldithiocarbamate influences galactosamine induced hepatitis in the rat. Experimental liver damage produced by galactosamine is less severe when diethyldithiocarbamate is given before or after galactosamine application. Galactosamine induced hepatitis is nearly completely suppressed when diethyldithiocarbamate is applied 24 h after galactosamine administration.
D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy* / Q000517:prevention & control; D004050:Ditiocarb / Q000627:therapeutic use*; D004798:Enzymes / Q000097:blood; D005688:Galactosamine / Q000037:antagonists & inhibitors* / Q000633:toxicity; D008297:Male; D051381:Rats; D013859:Thiocarbamates / Q000627:therapeutic use*
D004798:Enzymes; D013859:Thiocarbamates; D005688:Galactosamine; D004050:Ditiocarb
Protektiver und kurativer Effekt von Diethyldithiocarbamat auf die Galaktosamin-Hepatitis der Ratte.